| Income Statement | 2025-09-27 | 2025-06-28 | 2025-03-29 | 2024-09-28 |
|---|---|---|---|---|
| Net sales | 213,670 | 235,848 | 249,539 | 200,221 |
| Cost of sales | 48,815 | 50,184 | 52,445 | 39,257 |
| Gross profit | 164,855 | 185,664 | 197,094 | 160,964 |
| Brand partner incentives | 77,684 | 87,040 | - | - |
| Associate incentives | - | - | 89,985 | 84,068 |
| Selling, general and administrative | 85,947 | 81,906 | 91,438 | 61,295 |
| Total operating expenses | 163,631 | 168,946 | 181,423 | 145,363 |
| Earnings from operations | 1,224 | 16,718 | 15,671 | 15,601 |
| Interest income | 578 | 619 | 723 | 3,142 |
| Interest expense | 49 | 259 | 411 | 49 |
| Other, net | 41 | 1,739 | 756 | -86 |
| Other income (expense), net | 570 | 2,099 | 1,068 | 3,007 |
| Earnings before income taxes | 1,794 | 18,817 | 16,739 | 18,608 |
| Income taxes | 8,456 | 8,373 | 7,449 | 8,001 |
| Net (loss) earnings | -6,662 | 10,444 | 9,290 | - |
| Less net (loss) earnings attributable to redeemable noncontrolling interest | -140 | 789 | -112 | - |
| Net (loss) earnings attributable to usana | -6,522 | 9,655 | 9,402 | 10,607 |
| Tax benefit (expense) related to foreign currency translation adjustment | - | - | - | 845 |
| Foreign currency translation adjustment | - | - | - | 7,654 |
| Other comprehensive income (loss), net of tax | - | - | - | 6,809 |
| Comprehensive income | - | - | - | 17,416 |
| Basic (in dollars per share) | -0.36 | 0.52 | 0.49 | 0.56 |
| Basic (in shares) | 18,293,000 | 18,513,000 | 19,049,000 | 19,078,000 |
| Diluted (in dollars per share) | -0.36 | 0.52 | 0.49 | 0.56 |
| Diluted (in shares) | 18,293,000 | 18,536,000 | 19,085,000 | 19,083,000 |
USANA HEALTH SCIENCES INC (USNA)
USANA HEALTH SCIENCES INC (USNA)